Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

07_21 American Conference Institute

American Conference Institute’s 16th Advanced Forum on FCPA & Anti-Corruption for the Life Sciences Industry 

American Conference Institute’s 16th Advanced Forum on FCPA & Anti-Corruption for the Life Sciences Industry

Summary

Speakers

Jennifer L. Chunias

Related Content

SEC Launches Rule Proposal to Enable Expanded Use of Electronic Delivery for Required Investor Communications

SEC’s Office of Mergers and Acquisitions Issues Exemptive Order Easing Certain Requirements for Non-Convertible Debt Tender Offers

Supreme Court Clarifies Scope of SEC’s Disgorgement Authority

Expanding Corporate Criminal Liability in the UK: Key Impacts and Considerations for Organisations and Investors

SEC Proposes Rescission of Climate-Related Disclosure Rules

SEC Proposes Significant Changes to the Registered Offering Framework

The European Commission’s Draft Merger Guidelines: Considerations for Technology, Pharmaceutical, and Life Sciences

Post-Award Considerations and a Look to the Future (IAM)

Goodwin Strengthens Antitrust Platform with Addition of Margaret Webb

Securities Litigation Against Life Sciences Companies: Recent Trends and Updates

Goodwin Secures Summary Judgment Victory for Rocket Close in Pennsylvania “Junk” Fee Litigation

AI on the Docket: How AI is Transforming the Practice of Antitrust Law

Federal Circuit Bar Association’s 2026 Bench & Bar Conference

Hikma v. Amarin: What the Supreme Court's Decision Means for Skinny Labeling and Induced Infringement

The Legal 500 US 2026 Recognizes 47 Goodwin Practices and 185 Lawyers

DCIAA/EBRI/SPARK Public Policy Forum

Complex Litigation & Dispute Resolution

Litigation